TR199902482T1 - Stabil sivi mineral askorbat terkipleri yapim metodu ve bunlarin kullanimi - Google Patents

Stabil sivi mineral askorbat terkipleri yapim metodu ve bunlarin kullanimi

Info

Publication number
TR199902482T1
TR199902482T1 TR1999/02482T TR9902482T TR199902482T1 TR 199902482 T1 TR199902482 T1 TR 199902482T1 TR 1999/02482 T TR1999/02482 T TR 1999/02482T TR 9902482 T TR9902482 T TR 9902482T TR 199902482 T1 TR199902482 T1 TR 199902482T1
Authority
TR
Turkey
Prior art keywords
compound
concentrate
mineral ascorbate
solvent
pharmacologically acceptable
Prior art date
Application number
TR1999/02482T
Other languages
English (en)
Inventor
C.Hegenauer John
Original Assignee
Oxycal Laboratories, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxycal Laboratories, Inc. filed Critical Oxycal Laboratories, Inc.
Publication of TR199902482T1 publication Critical patent/TR199902482T1/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Emergency Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Sivi C vitamini konsantre terkipleri, yaklasik 5 ila 7 pH arasinda bir konsantreye sahip olup bir mineral askorbat ve farmasötik olarak kabul edilebilir sivi organik poliol solventi içerirler. Bunun yanisira konsantre bir aldonik bilesik ve/veya bir farmasötik olarak kabul edilebilir çinko bilesigi de içerebilir. Konsantre terkipler, solventin 50-90 C'de isitilmasi ve askorbat ve/veya aldonik bilesik ve/veya çinko bilesiginin, tercihen oksijen yok iken, bu solvente katilmasi ile olusturulurlar. Konsantre terkipler ayrica bir mineral askorbat ile farmasötik olarak kabul edilebilir sivi organik poliol solventin reaksiyon ürününü içermesi ile karakterize edilirler.
TR1999/02482T 1998-02-06 1999-02-05 Stabil sivi mineral askorbat terkipleri yapim metodu ve bunlarin kullanimi TR199902482T1 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9802333 1998-02-06
PCT/US1999/002735 WO1999039580A1 (en) 1998-02-06 1999-02-05 Stable liquid mineral ascorbate compositions and methods of manufacture and use

Publications (1)

Publication Number Publication Date
TR199902482T1 true TR199902482T1 (tr) 2002-10-21

Family

ID=22266349

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/02482T TR199902482T1 (tr) 1998-02-06 1999-02-05 Stabil sivi mineral askorbat terkipleri yapim metodu ve bunlarin kullanimi

Country Status (19)

Country Link
US (1) US6197813B1 (tr)
EP (1) EP0982990B1 (tr)
JP (1) JP4717166B2 (tr)
KR (1) KR100636991B1 (tr)
CN (1) CN1256943C (tr)
AT (1) ATE341938T1 (tr)
AU (1) AU744584B2 (tr)
CA (1) CA2275420C (tr)
DE (1) DE69933518T2 (tr)
DK (1) DK0982990T3 (tr)
ES (1) ES2274618T3 (tr)
HK (1) HK1028323A1 (tr)
IS (1) IS2560B (tr)
NO (1) NO328336B1 (tr)
NZ (1) NZ336188A (tr)
PT (1) PT982990E (tr)
TR (1) TR199902482T1 (tr)
TW (1) TWI227138B (tr)
WO (1) WO1999039580A1 (tr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001280448B8 (en) * 1998-01-05 2008-05-29 The Ester C Company Vitamin C Compositions
US6878744B2 (en) * 1999-02-05 2005-04-12 Oxycal Laboratories, Inc. Vitamin C compositions
US20040266673A1 (en) * 2002-07-31 2004-12-30 Peter Bakis Long lasting natriuretic peptide derivatives
US6887470B1 (en) 1999-09-10 2005-05-03 Conjuchem, Inc. Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
US7601691B2 (en) 1999-05-17 2009-10-13 Conjuchem Biotechnologies Inc. Anti-obesity agents
DE69939123D1 (de) * 1999-08-30 2008-08-28 Ester C Company Verwendungen und zusammensetzungen für selektive krebs-chemotherapie
CN1189159C (zh) * 2000-05-05 2005-02-16 欧莱雅 含水溶性美容活性组分水性核的微胶囊及含其的组合物
US6468980B1 (en) * 2000-09-01 2002-10-22 Oxycal Laboratories, Inc. Methods and compositions for potentiating cancer chemotherapeutic agents
JP2002265347A (ja) * 2001-03-13 2002-09-18 Shiseido Co Ltd コーニファイドエンベロープの成熟を促す化粧料
EP2859894A1 (en) 2001-06-26 2015-04-15 The Ester C Company Vitamin C compositions
DE10158447B4 (de) * 2001-11-30 2005-02-10 Aquanova German Solubilisate Technologies (Agt) Gmbh Ascorbinsäure-Solubilisat
AU2003284337B2 (en) * 2002-10-25 2010-04-15 Precision Dermatology, Inc. Modulation of zinc levels to improve tissue properties
EP1616486A1 (en) * 2004-07-13 2006-01-18 Friesland Brands B.V. Powdered compositions containing an edible oil and their use in food products
CA2575398C (en) * 2006-02-02 2011-12-20 Omp, Inc. Methods of treating skin to enhance therapeutic treatment thereof
US20070269534A1 (en) * 2006-02-02 2007-11-22 Ramirez Jose E Methods of treating skin to enhance therapeutic treatment thereof
ITTO20060782A1 (it) * 2006-11-02 2008-05-03 Mb Med S R L Procedimento per la preparazione di acido ascorbico o un suo sale da matrici vegetali
US20090099074A1 (en) * 2007-01-10 2009-04-16 Conjuchem Biotechnologies Inc. Modulating food intake
US7794585B2 (en) * 2007-10-15 2010-09-14 Uop Llc Hydrocarbon conversion process
JP5586713B2 (ja) * 2013-01-21 2014-09-10 サンエイ糖化株式会社 ミネラル可溶化安定剤
US10806692B2 (en) * 2016-10-03 2020-10-20 The Procter & Gamble Company Skin cleansing compositions comprising color stable abrasive particles
CN110151577A (zh) * 2019-06-18 2019-08-23 上海宜侬生物科技有限公司 含有l-抗坏血酸的化妆品组成物
CN111679000A (zh) * 2020-05-29 2020-09-18 费森尤斯卡比华瑞制药有限公司 检测肠内或肠外营养制剂中维生素c杂质的方法
US20230048204A1 (en) * 2021-08-12 2023-02-16 Jiayin BAO Skincare product and multi-dimensional ascorbic acid serum formulation therefor

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2400171A (en) * 1935-09-26 1946-05-14 Frances R Ruskin Stabilized metal ascorbates
US2585580A (en) * 1947-06-12 1952-02-12 Opplt Jan Stabilizing ascorbic acid with thio-sugars
US2822317A (en) * 1955-12-12 1958-02-04 Smith Kline French Lab Aqueous iron-ascorbic acid preparation
JPS6270309A (ja) * 1985-09-24 1987-03-31 Kanebo Ltd 美白化粧料
US4968716A (en) * 1987-04-10 1990-11-06 Oxycal Laboratories, Inc. Compositions and methods for administering therapeutically active compounds
AU2228888A (en) * 1987-10-14 1989-05-25 Takeda Chemical Industries Ltd. Aqueous pharmaceutical preparation for oral administration
US5173214A (en) * 1989-02-01 1992-12-22 Union Oil Company Of California Precursor composition for sols and gels
JP2977865B2 (ja) * 1989-06-23 1999-11-15 三省製薬株式会社 真皮部位に発症する色素沈着症治療剤
JPH04235925A (ja) * 1991-01-11 1992-08-25 Otsuka Pharmaceut Co Ltd 安定な総合ビタミン注射液
KR920019370A (ko) * 1991-04-26 1992-11-19 스야마 다다카즈 주입 제제
JPH04346926A (ja) * 1991-05-21 1992-12-02 Sumitomo Pharmaceut Co Ltd シロップ剤
US5696169A (en) * 1992-03-13 1997-12-09 Otsuka Pharmaceutical Co., Ltd. Antibacterial and antifungal activity method, therapeutic method of infectious diseases and preserving method of cosmetics
JP2654529B2 (ja) * 1992-03-27 1997-09-17 大塚製薬株式会社 健康飲料組成物
JPH0630746A (ja) * 1992-07-10 1994-02-08 Kanebo Ltd アスコルビン酸含有食品の安定化方法
WO1995014457A1 (en) * 1993-11-27 1995-06-01 Knoll Ag Compositions comprising iminium ion scavengers and/or nitrite scavengers
US5968533A (en) * 1994-11-15 1999-10-19 Porter; Steven S. Skin care compositions and methods
JP3483988B2 (ja) * 1995-06-01 2004-01-06 株式会社資生堂 皮膚外用剤
JPH0967254A (ja) * 1995-09-01 1997-03-11 Yoshihide Hagiwara 安定化されたビタミンｃ組成物
CN1069320C (zh) * 1995-10-17 2001-08-08 昭和电工株式会社 高纯度生育酚磷酸酯,其生产方法和含有该化合物的化妆品
JP3354768B2 (ja) * 1995-10-24 2002-12-09 カネボウ株式会社 皮膚化粧料
FR2742987B1 (fr) * 1996-01-03 1998-04-03 Lvmh Rech Utilisation dans le domaine de la cosmetique et de la pharmacie, notamment de la dermatologie, d'un extrait d'eriobotrya japonica pour stimuler la synthese des glycosaminoglycanes
US5906811A (en) * 1997-06-27 1999-05-25 Thione International, Inc. Intra-oral antioxidant preparations

Also Published As

Publication number Publication date
CA2275420C (en) 2007-05-29
NZ336188A (en) 2000-03-27
DE69933518D1 (de) 2006-11-23
AU744584B2 (en) 2002-02-28
WO1999039580A1 (en) 1999-08-12
CN1256943C (zh) 2006-05-24
HK1028323A1 (en) 2001-02-16
DE69933518T2 (de) 2007-08-23
IS5150A (is) 1999-08-06
TWI227138B (en) 2005-02-01
ATE341938T1 (de) 2006-11-15
EP0982990A4 (en) 2001-05-16
JP2002513426A (ja) 2002-05-08
CN1255829A (zh) 2000-06-07
EP0982990B1 (en) 2006-10-11
DK0982990T3 (da) 2007-02-12
NO994844D0 (no) 1999-10-05
EP0982990A1 (en) 2000-03-08
CA2275420A1 (en) 1999-08-06
NO328336B1 (no) 2010-02-01
NO994844L (no) 1999-10-05
JP4717166B2 (ja) 2011-07-06
ES2274618T3 (es) 2007-05-16
KR20010006081A (ko) 2001-01-15
PT982990E (pt) 2007-01-31
US6197813B1 (en) 2001-03-06
IS2560B (is) 2009-11-15
AU2664799A (en) 1999-08-23
KR100636991B1 (ko) 2006-10-23

Similar Documents

Publication Publication Date Title
TR199902482T1 (tr) Stabil sivi mineral askorbat terkipleri yapim metodu ve bunlarin kullanimi
IL109526A0 (en) Benzofuranyl- and thiophenyl-alkanecarboxylic acid derivatives, their preparation and pharmaceutical compositions containing them
MXPA04001231A (es) Composiciones topicas para aplicar y no enjuagar que contiene derivados seleccionados del acido pantotenico.
HRP960508A2 (en) A method of enhancing cellular production of molecular chaperon,hydroxalamine derivatives useful for enhancing the chaperon production and the preparation thereof
WO2004022529A3 (en) Diarylurea derivatives and their use as chloride channel blockers
HUT49600A (en) Process for producing substituted flavonoid deriatives and salts, thereof, as well as pharmaceutical compositions comprising such compounds
DE69815750D1 (de) Verfahren zur Herstellung von Ascorbinsäurederivaten
IL86456A (en) Tetrazole derivatives useful as intermediates for preparing antihypertensive compounds
CS782686A2 (en) Method of benzimidazole derivatives production
ATE382343T1 (de) Polyphenole enthaltende pharmazeutische nahrungsmittelergänzungsformel und ihre anwendung in der krebsbehandlung
AU3287200A (en) Composition comprising isoquercetin and ascorbic acid in a sustained release form
MXPA04007068A (es) Derivados de almidon, conjugados de almidon con sustancia activa, metodo para su produccion y su uso como medicamentos.
MY114944A (en) Propanolamine derivatives, processes for their preparation pharmaceuticals comprising these compounds, and their use
MY117323A (en) Method of scavenging free radicals using orange extract
AU2001286003A1 (en) Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
KR970032819A (ko) 미백화장료 조성물
IL91212A0 (en) 6-fluoro-3,5-dihydroxy carboxylic acids and derivatives thereof,a process for the preparation thereof and pharmaceutical compositions containing them
DE50310932D1 (de) Sporopollenin enthaltende lösliche zusammensetzung und verwendung
DE69801811D1 (de) Alkykendiamin di- oder tri-essigsäurederivate, verfahren zu ihrer herstellung und ihre verwendung in kosmetischen zusammensetzungen
ATE355281T1 (de) 1,4,7,10-tetraazacyclododecan-1,4-diessigsäure
WO2000057840A3 (en) Dermatological topical composition
BG105618A (en) Beta-amido and beta-sulphonamide derivatives of carboxylic acids, method for preparation and application as endothelin-receptor antagonists
FI20000956A0 (fi) Kosmeettinen tai ihonhoidollinen voidekoostumus, sen valmistusmenetelmä ja käyttö
EP1232748A4 (en) SUBSTITUTED NITROBENZENE-LIKE DERIVATIVE PRODUCT AS A MEDICINAL PRODUCT OR OTHER EFFICIENT PRODUCTS
WO2003040119A8 (fr) Inhibiteurs de l'angiogenese